Aggregate Spend
AGGREGATE SPEND ARTICLES
-
Advancements In Gene Therapy Development
Gene therapy is transforming treatment for genetic disorders. With over 30 FDA-approved therapies, gain expert insight into how digital PCR enhances AAV vector precision, safety, and regulatory compliance in development.
AGGREGATE SPEND SOFTWARE WHITE PAPERS AND CASE STUDIES
-
Breaking Barriers In Malaria Prevention With A Mobile Cleanroom
The delivery of this mobile cGMP cleanroom facility to ACT showcases Germfree’s commitment to providing innovative solutions that meet clients' unique needs and contribute to advancing healthcare.
-
A Universal Solution For Ultra Cold Storage
Learn how an ultra-low temperature freezer standardizes cold storage, increases storage density, and ensures stable temperatures to achieve compliance and sustainability across packaging formats.
-
Understanding Complexities Of Bioabsorbable Materials Achieves Consistent IV Loss
Expertise in bioabsorbable materials led to success in a major medical device challenge through a tailored approach, equipment, and proven protocols.
AGGREGATE SPEND SOFTWARE NEWS
-
Climate-Ready Crop: RIPE Team Shows Increase In Food Mass Through Photorespiratory Bypass In Elevated Temperatures12/4/2024
A team from the University of Illinois has engineered potato to be more resilient to global warming, showing 30% increases in tuber mass under heatwave conditions.
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
-
How Lakes Connect To Groundwater Critical For Resilience To Climate Change7/9/2025
The study drew on data from 350 lakes across 18 European countries, collected between 2022 and 2024, to provide a comprehensive picture of how the continent’s lakes are coping with climate change.
-
Celestia TTI Brings Unique GaN Based SSPAs In DBS Band To Broadcast Satcom5/16/2024
Satellite operators running large teleport operations and satellite broadcasters seeking the ultimate technology to power their businesses now have a range of options to choose from thanks to a new generation of GaN SSPAs in DBS introduced to the market by Celestia TTI.
-
Plants Don't Just Feel The Heat – They Decode It Through A Molecular Network6/13/2025
In a new framework that could reshape how we engineer crops for a warming world, scientists have revealed that plants don't rely on a single "thermometer" to sense temperature.
ABOUT
Aggregate Spend
Aggregate Spend refers to the process used to aggregate and monitor the total amount spent on organizations and individual healthcare professionals by healthcare manufacturers. The amount spent is aggregated in terms of payments made, honoraria, gifts, travel and other means. Aggregate spend is also known as the Physician Spend Sunshine Law which is an initiative that is aimed to achieve transparency in life sciences industry, the benefits of each physician as well as to limit spend per physician. The law is a body of state and federal legislations. Passing of this law was also in effort to alleviate the conflicts of interest between pharmaceutical and medical device companies and healthcare professionals.
The process requires that manufactures of various medical devices, drugs, biological and other supplies recorded all payments made to physicians including any other transfers of value to teaching hospitals and physicians. Report regarding all this information is required to be produced annually by all the applicable manufacturers and suppliers. The manufacturers are required to include details such as date, nature of payment and the value. Penalties are charged in case of breaching this law by the target parties.
By doing this, accountability of individual physicians and medical device, pharmaceutical and life sciences companies can be achieved. The challenge now is to the life science companies to address the reporting requirements and more so now that state and federal regulatory agency continue to enact legislation that require more auditing of monetary transactions to physicians and organizations involved in healthcare management. As a result many companies are now working more diligently to address compliance and gain more competitive advantage through reputation management among other ways.